NASDAQ: NXTC · Biotechnology
Over the past week, Nextcure (NXTC) logged about 27 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 22% bullish but is at odds: X runs 38% bullish while News sits at just 0%. Wall Street is more constructive, with 3 of 3 analysts rating NXTC a buy.
“NXTC is trending because a major short squeeze setup is getting extremely interesting, with optimism around a sharp increase in buying interest offset by concern about potential short covering.”Adanos /explain
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 0% to X at 38%. No other tracker puts the two side by side.
3 analysts have weighed in: a Strong Buy consensus: 3 buy calls against 0 sell, with an average 12-month price target of $20.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 78 points above the crowd average of 22%, the professionals are more constructive than retail. The split is inside the crowd: X reads 38% bullish while News sits at 0%, a 38-point spread that single-source trackers miss.
Over the 30-day window, Nextcure (NXTC) buzz held subdued around 24.4 while the price drifted up 37.1% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 505K shares. Updated Aug 15, 2026. Over the last 7 trading days, NXTC gained 46.9%. Buzz activity in the recent week averaged 26.1 and was variable, swinging between 15.4 and 38.7. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 7 of the 13 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for NXTC and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live NXTC sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (3 / 0 / 0) |
| Crowd bullish (7d) | 22% |
| Avg price target | $20.00 |
| Most bullish source | X, 38% |
| Most bearish source | News, 0% |
| Sentiment spread | 38 pts |
| Mentions (7d) | 27 |
| Market cap | $37.6M |
| EPS · Beta | -$8.28 · 1.3 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Nextcure (NXTC) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 22% bullish across 3 active sources. Those sources contribute 27 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Nextcure (NXTC) is fairly quiet with 15 mentions over the last 7 days; the 30-day context spans 6 tracked subreddits. The 7-day tone is 27% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads bearish on Nextcure (NXTC), averaging 22% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 38% bullish and News at 0%, a 38-point spread. On the professional side, 3 of 3 analysts rate NXTC a buy.
Of the 3 analysts covering Nextcure (NXTC), 3 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $20.00. That puts the street ahead of the crowd, which averages 22% bullish.
Nextcure (NXTC)'s cross-source average is bearish at 22% bullish. All 3 tracked sources lean bearish. Reddit reads 27% bullish, X reads 38% bullish and news coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Nextcure (NXTC) at 22% bullish. All 3 tracked sources lean bearish. The most bearish reading is news at 0% bullish. 3-day activity momentum is rising across Reddit and News. The sell signal carries 93/100 conviction.
Reddit is the dominant discussion channel with 15 mentions (56% of total volume). X contributes 8 mentions and News contributes 4 mentions. The cross-source average is bearish at 22% bullish, while reddit and news show rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. NXTC's sell signal at 93/100 conviction reflects a bearish cross-source average at 22% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The NXTC sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key